Temporary contraindication to chemotherapy due to toxicity: blinatumomab's effectiveness in paediatric patients with B-acute lymphoblastic leukaemia

Affiliations

• ¹ Pediatric Intensive Care Unit, APHP University Hospital Necker-Enfants Malades, Paris, France.
• ² Institute of Pediatric Hematology and Oncology, Hospices Civils de Lyon, Université Lyon 1, Lyon, France.
• ³ Pediatrics Oncology Department, Children's Hospital of Bordeaux University Hospital, Bordeaux, France.
• ⁴ Pediatric Hematology-Oncology Unit, CHU Reims, Reims, France.
• ⁵ Pediatric Hematology Unit, CHU Lille, Lille, France.
• ⁶ Pediatric Hematology-Oncology Unit, CHU Toulouse, Toulouse, France.
• ⁷ Pediatric Hematology-Oncology Unit, CHU Besançon, Besançon, France.
• ⁸ Sorbonne Université, Hôpital Armand Trousseau, AP-HP, Paris, France.
• ⁹ Pediatric Hematology-Oncology Unit, CHU Nantes, Nantes, France.
• ¹⁰ Hematology and Immunology Pediatric Unit, Robert Debré Hospital, Paris, France.